Eiminda, Ltd.
IsraelFDA applicant, unverified
- Devices
- 1
What Eiminda, Ltd. makes
Eiminda, Ltd. manufactures the BNA Analysis System, a device designed for breast tissue characterization and assessment, likely used in diagnostic imaging workflows to evaluate breast density and lesion characteristics.
The BNA Analysis System is classified as a Class II medical device in the U.S. and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Bna Analysis System Ref K121119
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Eiminda, Ltd. have in the registry?
The registry currently lists 1 device for Eiminda, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Eiminda, Ltd.'s devices?
Among its 1 most recently registered device, Eiminda, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Eiminda, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Eiminda, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Eiminda, Ltd. in the registry?
The most recently registered devices listed for Eiminda, Ltd. include BNA ANALYSIS SYSTEM.